{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:25:20Z","timestamp":1759422320175},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Crescendo Bioscience"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10067-018-4276-y","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:36:05Z","timestamp":1535600165000},"page":"437-445","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores"],"prefix":"10.1007","volume":"38","author":[{"given":"David","family":"Chernoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Scott Eastman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching Chang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Darl D.","family":"Flake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"issue":"6","key":"4276_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Po\u00f3r G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4276_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4276_CR3","first-page":"1","volume":"68","author":"JA Singh","year":"2015","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2015) American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis & rheumatology (Hoboken, NJ). 2016 68(1):1\u201326","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"3","key":"4276_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4276_CR5","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis research & therapy 7(4):R796\u2013R806","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"4276_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N (2007) Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 66(3):407\u2013409","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4276_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford, England) 42(2):244\u2013257","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"4276_CR8","first-page":"211","volume":"67","author":"T Pincus","year":"2009","unstructured":"Pincus T, Bergman MJ, Yazici Y (2009) RAPID3-an index of physical function, pain, and global status as \u201cvital signs\u201d to improve care for people with chronic rheumatic diseases. Bulletin of the NYU hospital for joint diseases 67(2):211\u2013225","journal-title":"Bulletin of the NYU hospital for joint diseases"},{"issue":"4","key":"4276_CR9","doi-asserted-by":"publisher","first-page":"e60635","DOI":"10.1371\/journal.pone.0060635","volume":"8","author":"M Centola","year":"2013","unstructured":"Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR (2013) Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One 8(4):e60635","journal-title":"PLoS One"},{"issue":"12","key":"4276_CR10","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/acr.21767","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick NA, Hamburger M, Fleischmann R, Keystone E, Weinblatt ME (2012) Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care Res 64(12):1794\u20131803","journal-title":"Arthritis Care Res"},{"issue":"10","key":"4276_CR11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-013-2300-9","volume":"32","author":"C Heegaard","year":"2013","unstructured":"Heegaard C, Dreyer L, Egsmose C, Madsen OR (2013) Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints. Clin Rheumatol 32(10):1493\u20131500","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4276_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/ard.2008.097345","volume":"68","author":"T Uhlig","year":"2009","unstructured":"Uhlig T, Kvien TK, Pincus T (2009) Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 68(6):972\u2013975","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4276_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM Gestel van","year":"1996","unstructured":"van Gestel AM, Prevoo ML, Van \u2019t Hof MA, van Rijswijk MH, van de Putte LB, van riel PL (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum 39(1):34\u201340","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"4276_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jim.2012.02.007","volume":"378","author":"X Zhao","year":"2012","unstructured":"Zhao X, Qureshi F, Eastman PS, Manning WC, Alexander C, Robinson WH, Hesterberg LK (2012) Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J Immunol Methods 378(1\u20132):72\u201380","journal-title":"J Immunol Methods"},{"key":"4276_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jpba.2012.06.003","volume":"70","author":"PS Eastman","year":"2012","unstructured":"Eastman PS, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK (2012) Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis. J Pharm Biomed Anal 70:415\u2013424","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"4276_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/ard.53.8.521","volume":"53","author":"NG Arvidson","year":"1994","unstructured":"Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R (1994) Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 53(8):521\u2013524","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4276_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/art.22368","volume":"56","author":"RH Straub","year":"2007","unstructured":"Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56(2):399\u2013408","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4276_CR18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4276_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, Van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4276_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/annrheumdis-2012-202450","volume":"72","author":"GR Burmester","year":"2013","unstructured":"Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M et al (2013) Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis 72(9):1445\u20131452","journal-title":"Ann Rheum Dis"},{"key":"4276_CR21","doi-asserted-by":"crossref","unstructured":"Fraser Callum G (2012) Reference change values. Clin Chem Lab Med. p. 807","DOI":"10.1515\/cclm.2011.733"},{"key":"4276_CR22","doi-asserted-by":"crossref","unstructured":"Curtis JR, Flake D, Weinblatt M, Shadick N, Ostergaard M, Hetland M, et al. (2018) Development of an adjusted multi-biomarker disease activity score for rheumatoid arthritis that accounts for age, gender and adiposity with subsequent evaluation of ability to predict risk for radiographic damage. Rheumatology. submitted","DOI":"10.1136\/annrheumdis-2018-eular.7133"},{"key":"4276_CR23","doi-asserted-by":"crossref","unstructured":"Curtis JR, Chen L, Danila MI, Saag KG, Parham KL, Cush JJ (2017) Routine use of quantitative disease activity measurements among US rheumatologists: implications for treat-to-target management strategies in rheumatoid arthritis. J Rheumatol","DOI":"10.3899\/jrheum.170548"},{"issue":"3","key":"4276_CR24","first-page":"216","volume":"66","author":"T Pincus","year":"2008","unstructured":"Pincus T, Furer V, Keystone E, Yazici Y, Bergman MJ, Luijtens K (2008) Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bulletin of the NYU hospital for joint diseases 66(3):216\u2013223","journal-title":"Bulletin of the NYU hospital for joint diseases"},{"issue":"6","key":"4276_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/ard.2005.044230","volume":"65","author":"T Pincus","year":"2006","unstructured":"Pincus T, Segurado OG (2006) Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 65(6):820\u2013822","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4276_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.semarthrit.2013.11.003","volume":"43","author":"PP Cheung","year":"2014","unstructured":"Cheung PP, Gossec L, Mak A, March L (2014) Reliability of joint count assessment in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 43(6):721\u2013729","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"4276_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.rdc.2009.10.004","volume":"35","author":"T Sokka","year":"2009","unstructured":"Sokka T, Pincus T (2009) Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin N Am 35(4):713\u2013722 v-vi","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"4276_CR28","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/ar4469","volume":"16","author":"J Kay","year":"2014","unstructured":"Kay J, Morgacheva O, Messing SP, Kremer JM, Greenberg JD, Reed GW, Gravallese EM, Furst DE (2014) Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis research & therapy 16(1):R40","journal-title":"Arthritis research & therapy"},{"issue":"10","key":"4276_CR29","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"AK Brown","year":"2008","unstructured":"Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58(10):2958\u20132967","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4276_CR30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/annrheumdis-2013-204986","volume":"74","author":"K Hambardzumyan","year":"2015","unstructured":"Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF (2015) Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Ann Rheum Dis 74(6):1102\u20131109","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4276_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/rheumatology\/kev341","volume":"55","author":"W Li","year":"2016","unstructured":"Li W, Sasso EH, van der Helm-van Mil AH, Huizinga TW (2016) Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis. Rheumatology 55(2):357\u2013366","journal-title":"Rheumatology"},{"issue":"11","key":"4276_CR32","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3899\/jrheum.131412","volume":"41","author":"IM Markusse","year":"2014","unstructured":"Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJSM, Lems WF, Huizinga TWJ, Allaart CF (2014) A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study. J Rheumatol 41(11):2114\u20132119","journal-title":"J Rheumatol"},{"issue":"5","key":"4276_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/kes378","volume":"52","author":"AH Mil van der Helm-van","year":"2013","unstructured":"van der Helm-van Mil AH, Knevel R, Cavet G, Huizinga TW, Haney DJ (2013) An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression. Rheumatology 52(5):839\u2013846","journal-title":"Rheumatology"},{"key":"4276_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/00016489309126195","volume":"500","author":"M Ino","year":"1993","unstructured":"Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T (1993) Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl 500:126\u2013130","journal-title":"Acta Otolaryngol Suppl"},{"issue":"5","key":"4276_CR35","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1210\/jcem.83.5.4717","volume":"83","author":"JG Langendonk","year":"1998","unstructured":"Langendonk JG, Pijl H, Toornvliet AC, Burggraaf J, Frolich M, Schoemaker RC et al (1998) Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab 83(5):1706\u20131712","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4276_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/ard.2007.086561","volume":"68","author":"MG Perry","year":"2009","unstructured":"Perry MG, Kirwan JR, Jessop DS, Hunt LP (2009) Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68(1):63\u201368","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4276_CR37","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/annrheumdis-2013-205079","volume":"74","author":"MM Ward","year":"2015","unstructured":"Ward MM, Guthrie LC, Alba MI (2015) Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials. Ann Rheum Dis 74(9):1691\u20131696","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4276_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/acr.22606","volume":"67","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, Boire G, Thorne JC, Tin D, Hitchon CA, Bingham CO III, Bykerk VP (2015) Determining the minimally important difference in the clinical disease activity index for improvement and worsening in early rheumatoid arthritis patients. Arthritis Care Res 67(10):1345\u20131353","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4276-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4276-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4276-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T21:44:12Z","timestamp":1581975852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4276-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4276"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4276-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"D. Chernoff Shareholder of: Myriad Genetics, Inc., Employee of: Crescendo Bioscience Inc., P. S. Eastman Shareholder of: Myriad Genetics, Inc., Employee of: Crescendo Bioscience Inc., C. C. Hwang Shareholder of: Myriad Genetics, Inc., Employee of: Crescendo Bioscience Inc., D. Flake Shareholder of: Myriad Genetics, Inc., Employee of: Myriad Genetics, Inc., X. Wang Shareholder of: Myriad Genetics, Inc., Employee of: Crescendo Bioscience Inc., A. Kivitz Consultant for: Genentech, Pfizer, UCB, Janssen, Novartis Abvie, J. Curtis Grant\/research support from: Crescendo Bioscience Inc., Consultant for: Crescendo Bioscience Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}